Nuzenio

Hemab Therapeutics

Hemab Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 13:32:14 GMTHemab Therapeutics (NASDAQ: COAG) investors detail 5.1% passive ownership stake - Stock Titan
Thu, 06 Aug 2026 16:47:28 GMTHemab Therapeutics (NASDAQ:COAG) Hits New 1-Year High - Time to Buy? - MarketBeat
Thu, 06 Aug 2026 14:28:55 GMTFMR LLC reports 7.9% Hemab Therapeutics (COAG) stake on Schedule 13G - Stock Titan
Wed, 05 Aug 2026 14:38:35 GMTSofinnova group (NASDAQ: COAG) discloses 5.4% Hemab Therapeutics ownership on Schedule 13G - Stock Titan
Mon, 03 Aug 2026 19:35:10 GMTHemab Therapeutics (NASDAQ:COAG) Trading Down 4.8% - What's Next? - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Hemab Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.